A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy

A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy

Bibliographic Details
Main Authors:	DAI Mingjia, YAN Xuebing
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2015-10-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=6901

Similar Items

Interpretation and analysis of EASL recommendations on treatment of hepatitis C 2016
by: SHEN Shanshan, et al.
Published: (2016-12-01)

Several opinions on EASL recommendations on treatment of hepatitis C (April 2014)
by: DAI Mingjia
Published: (2014-08-01)

EASL clinical practice guidelines (2015): autoimmune hepatitis
by: WANG Qixia, et al.
Published: (2015-12-01)

A comparison of 2015 and 2016 EASL guidelines on treatment of hepatitis C: an analysis of direct-acting antiviral agents and drug-drug interaction
by: JI Weijia, et al.
Published: (2017-06-01)

Recommendations for EASL clinical practice guidelines: liver transplantation（2015）
by: SHI Yinghong, et al.
Published: (2016-03-01)

An excerpt of 2015 EASL clinical practical guidelines: vascular diseases of the liver
by: GAO Fan, et al.
Published: (2016-01-01)

EASL recommendations on treatment of hepatitis C 2015
by: RAO Huiying, et al.
Published: (2015-07-01)

Recommendations for EASL cinical pactice guidelines on the prevention, diagnosis and therapy of gallstones (2016)
by: YE Junfeng, et al.
Published: (2016-07-01)

Interpretation of 2015 WHO guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection: comparison antiviral treatment of chronic hepatitis B
by: DAI Mingjia, et al.
Published: (2015-07-01)

An excerpt of EASL clinical practice guideline: Occupational liver diseases (2019)
by: LI Fan
Published: (2020-02-01)

EASL clinical practice guidelines on the management of benign liver tumors (2016)
by: HUANG Cheng, et al.
Published: (2015-08-01)

EASL clinical practical guidelines on the management of acute(fulminant) liver failure(2017)
by: YANG Min, et al.
Published: (2017-10-01)

Interpretation of the practice guidelines for alcoholic liver disease by EASL in 2012 and AASLD in 2010
by: CHANG Binxia
Published: (2015-01-01)

The highlights of EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection
by: YU Yuecheng, et al.
Published: (2017-06-01)

Key points and interpretation of EASL clinical practice guidelines: Drug-induced liver injury（2019）
by: YU Yuecheng
Published: (2019-06-01)

An excerpt of EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis(2017)
by: SUN Chunyan, et al.
Published: (2017-10-01)

Updated key points of the 2019 EASL guidelines for drug-induced liver injury and its practice in China
by: YU Hong
Published: (2020-03-01)

EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis
by: LI Peng, et al.
Published: (2015-08-01)

EASL recommendations on treatment of hepatitis C 2016
by: ZHANG Ying, et al.
Published: (2016-12-01)

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
Published: (2016-04-01)

An excerpt of EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease(2016)
by: CHANG Binxia, et al.
Published: (2016-07-01)

EASL-EASD-EASO Clinical practice guidelines for the management of nonalcoholic fatty liver disease: is universal screening appropriate?
by: Byrne, C., et al.
Published: (2016)

JHEP Reports: A new EASL open access journal
by: Jessica Zucman-Rossi
Published: (2019-05-01)

EASL recommendations on treatment of hepatitis C: Final update of the series (2020)
by: YANG Jia
Published: (2020-12-01)

Highlights from Barcelona 2012 International Liver Congress and EASL meeting
by: Julio C Aguilar

An excerpt of role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) clinical guideline (2017)
by: DING Min, et al.
Published: (2017-10-01)

Impact of HCV 5′NCR genetic mutation on standard program of anti-HCV therapy
by: MAO Weiwu
Published: (2015-04-01)

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
by: Jong Eun Yeon
Published: (2018-09-01)

Comparative studies in detection of anti-HCV antibodies using Abbott IMx HCV, Serodia-HCV and DETECT-HCVTM
by: Nisarat Apichartpiyakul, et al.
Published: (2010-01-01)

Adult antiretroviral therapy guidelines 2014
by: G. Meintjes
Published: (2014-01-01)

ANTI-HCV. CONFRONTO TRA SISTEMI IN AUTOMAZIONE.ANTI-HCV-ARCHITECT (ABBOTT) VERSO ANTI-HCV-VITROS (ORTHO).
by: M. Marinelli, et al.
Published: (2003-06-01)

Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study.
by: Shih-Yi Lin, et al.
Published: (2017-01-01)

Press-reliz44-e ezhegodnoe zasedanie Evropeyskoy assotsiatsii po izucheniyu pecheni (EASL)
by: - -
Published: (2009-06-01)

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
by: Tobias Boettler, et al.
Published: (2020-06-01)

An excerpt of care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID expert consensus(2020)
by: ZHENG Kexin
Published: (2020-05-01)

Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community
by: Wei-Ming Chen, et al.
Published: (2021-05-01)

Non-invasive diagnostic criteria of hepatocellular carcinoma: Comparison of diagnostic accuracy of updated LI-RADS with clinical practice guidelines of OPTN-UNOS, AASLD, NCCN, EASL-EORTC, and KLSCG-NCC.
by: Burcu Erkan, et al.
Published: (2019-01-01)

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.
by: Bruno Vincenzi, et al.
Published: (2015-01-01)

Direct anti-HCV agents
by: Xingquan Zhang
Published: (2016-01-01)

HBV and HCV Therapy
by: Massimo Colombo, et al.
Published: (2009-10-01)